End Taxpayer Subsidies for Drug Ads Act

Summary

End Taxpayer Subsidies for Drug Ads Act This bill prohibits tax deductions for expenses relating to direct-to-consumer advertising of prescription drugs. Direct-to-consumer advertising is any dissemination, by or on behalf of a sponsor of a prescription drug product, of an advertisement that is (1) in regard to the drug product, and (2) primarily targeted to the general public.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

1. 25 September 2020

   Introduced

   Referred to the House Committee on Ways and Means.

   Source: IntroReferral

2. 25 September 2020

   Introduced

   Introduced in House

   Source: IntroReferral

3. 25 September 2020

   Introduced

   Introduced in House

   Source: IntroReferral

Votes

No vote records are attached yet.

Versions

• Introduced in House · 25 September 2020 · Official file

Documents

3 official files

• Introduced in House (text)

  Introduced in House · EN · 25 September 2020

  ViewDownloadOpen at official source

• Introduced in House (PDF)

  Introduced in House · EN · 25 September 2020

  ViewDownloadOpen at official source

• Introduced in House

  summary · EN · 25 September 2020

  Open at official source

Sponsors

• Abby Finkenauer · D · Sponsor
• Sen. Slotkin, Elissa [D-MI] · D · Sponsor
• David Trone · D · Cosponsor
• · hswm00 · Standing

Related records

• related to → Affordable Medications Act
• related to → End Taxpayer Subsidies for Drug Ads Act